Legal & General Group PLC Travere Therapeutics, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 78,963 shares of TVTX stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,963

Previous 90,972 13.2%

Holding current value

$1.56 Million

Previous $1.27 Million 8.1%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$13.65 - $19.85 $163,922 - $238,378	-12,009 Reduced 13.2%	78,963 $1.38 Million
Q3 2024 Feb 28, 2025	BUY	$7.89 - $15.21 $15,740 - $30,343	1,995 Added 2.53%	80,958 $1.13 Million
Q3 2024 Nov 14, 2024	BUY	$7.89 - $15.21 $102,538 - $197,669	12,996 Added 16.67%	90,972 $1.27 Million
Q2 2024 Aug 14, 2024	BUY	$5.26 - $8.28 $14,848 - $23,374	2,823 Added 3.76%	77,976 $640,000
Q1 2024 May 14, 2024	SELL	$7.18 - $9.82 $428,638 - $586,244	-59,699 Reduced 44.27%	75,153 $579,000
Q4 2023 Feb 15, 2024	SELL	$5.44 - $9.5 $201,769 - $352,355	-37,090 Reduced 21.57%	134,852 $1.21 Million
Q3 2023 Nov 14, 2023	BUY	$7.64 - $17.25 $278,126 - $627,969	36,404 Added 26.86%	171,942 $1.54 Million
Q2 2023 Aug 14, 2023	BUY	$15.3 - $22.61 $157,681 - $233,018	10,306 Added 8.23%	135,538 $2.08 Million
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $889,912 - $1.14 Million	49,939 Added 66.33%	125,232 $2.82 Million
Q4 2022 Feb 14, 2023	BUY	$18.47 - $26.14 $207,067 - $293,055	11,211 Added 17.49%	75,293 $1.58 Million
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $950,329 - $1.19 Million	41,481 Added 183.54%	64,082 $1.58 Million
Q2 2022 Aug 22, 2022	BUY	$20.94 - $30.01 $20,039 - $28,719	957 Added 4.42%	22,601 $548,000
Q1 2022 May 16, 2022	BUY	$23.61 - $30.6 $7,035 - $9,118	298 Added 1.4%	21,644 $558,000
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $2,628 - $3,366	108 Added 0.51%	21,346 $663,000
Q3 2021 Nov 15, 2021	BUY	$12.98 - $25.03 $140,391 - $270,724	10,816 Added 103.78%	21,238 $515,000
Q2 2021 Aug 12, 2021	SELL	$14.11 - $26.4 $16,805 - $31,442	-1,191 Reduced 10.26%	10,422 $152,000
Q1 2021 May 17, 2021	BUY	$23.37 - $31.77 $40,149 - $54,580	1,718 Added 17.36%	11,613 $290,000
Q4 2020 Feb 12, 2021	BUY	$19.17 - $27.87 $189,687 - $275,773	9,895 New	9,895 $270,000

Others Institutions Holding TVTX

# of Institutions

214

Shares Held

94.3M

Call Options Held

1.2M

Put Options Held

778K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.27B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Travere Therapeutics, Inc. Transaction History